Catalyst Wire Dossier Catalyst Wire Dossier

Octohydroaminoacridine Succinate Tablets

octohydroaminoacridine succinate · Changchun Huayang High-tech Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Octohydroaminoacridine Succinate Tablets, covering 2012-04-09 to 2012-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease [Phase 2]

See pricing